CBD is not converted to THC in rats: A framework interpretation and discussion
| Authors | |
|---|---|
| Year of publication | 2021 |
| Type | Article in Periodical |
| Magazine / Source | European Neuropsychopharmacology |
| MU Faculty or unit | |
| Citation | |
| Web | https://www.sciencedirect.com/science/article/pii/S0924977X21001917?via%3Dihub |
| Doi | http://dx.doi.org/10.1016/j.euroneuro.2021.04.003 |
| Keywords | CBD; THC; rats |
| Description | Cannabidiol (CBD) is a non-psychotropic exogenous cannabinoid that is an active component in a number of topical and oral preparations. The pharmacological potential of CBD is determined by its anti-inflammatory and immuno- or neuromodulatory activities. This natural terpenoid is widely used today, and therefore more attention is now paid to examining its safety after the administration of high doses (Epidiolex) and also after low-dose chronic exposure, e.g. in the form of food supplements. CBD is therefore a molecule that has recently gained a great deal of scientific interest, both at the level of basic research and industrial development. |